{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:58:50Z","timestamp":1790963930117,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Diagnostic imaging of peritoneal metastases in ovarian and colorectal cancer remains pivotal in selecting the most appropriate treatment and balancing clinical benefit with treatment-related morbidity and mortality. To address the challenges related to diagnostic imaging and detecting and reporting peritoneal metastatic spread, a joint guideline was created by the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Society of Urogenital Radiology (ESUR), Peritoneal Surface Oncology Group International (PSOGI), and European Association of Nuclear Medicine (EANM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A targeted literature search was performed and consensus recommendations were proposed using Delphi questionnaires and a five-point Likert scale.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of three Delphi rounds were performed. Consensus was reached on the position of diagnostic imaging for assessment of operability, treatment response monitoring, and follow-up of peritoneal metastases, optimal imaging modality and their technical imaging requirements depending on the indication and how to optimise communication of imaging results by the report and multidisciplinary board discussion. The complete list of recommendations is provided.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These expert consensus statements aim to guide appropriate indications, acquisition, interpretation, and reporting of imaging for operability assessment, treatment response monitoring, and follow-up of peritoneal metastases in ovarian and colorectal cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Question<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Staging peritoneal metastases (PM) helps to\u00a0guide clinical decision-making for colorectal and ovarian cancer patients. How can we optimise the use of imaging techniques to assess PM?<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Findings<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Imaging plays a crucial role in the detection, operability assessment, treatment response monitoring, and follow-up of peritoneal metastases in colorectal and ovarian cancer patients.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Clinical relevance<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>These expert consensus statements aim to guide appropriate indication, acquisition, interpretation, and reporting of imaging for operability assessment, treatment response monitoring, and follow-up of peritoneal metastases in ovarian and colorectal cancer patients.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00330-024-11124-5","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:53:40Z","timestamp":1730822020000},"page":"2712-2722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM"],"prefix":"10.1007","volume":"35","author":[{"given":"Vincent","family":"Vandecaveye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Nougaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Stepanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Otero-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Nikoli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolien","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-202X","authenticated-orcid":false,"given":"Max J.","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the European Society of Gastrointestinal and Abdominal Radiology (ESGAR)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"European Society of Urogenital Radiology (ESUR)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Peritoneal Surface Oncology Group International (PSOGI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"European Association of Nuclear Medicine (EANM)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"11124_CR1","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-013-3461-0","volume":"21","author":"HC van Santvoort","year":"2014","unstructured":"van Santvoort HC, Braam HJ, Spekreijse KR et al (2014) Peritoneal carcinomatosis in T4 colorectal cancer: occurrence and risk factors. Ann Surg Oncol 21:1686\u20131691. https:\/\/doi.org\/10.1245\/s10434-013-3461-0","journal-title":"Ann Surg Oncol"},{"key":"11124_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","volume":"47","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Bakkers C, Rijken A et al (2021) Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. Eur J Surg Oncol 47:1026\u20131033. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.135","journal-title":"Eur J Surg Oncol"},{"key":"11124_CR3","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.clcc.2015.12.006","volume":"15","author":"LGEM Razenberg","year":"2016","unstructured":"Razenberg LGEM, van Gestel YRBM, Lemmens VEPP et al (2016) Bevacizumab in addition to palliative chemotherapy for patients with peritoneal carcinomatosis of colorectal origin: a nationwide population-based study. Clin Colorectal Cancer 15:e41\u2013e46. https:\/\/doi.org\/10.1016\/j.clcc.2015.12.006","journal-title":"Clin Colorectal Cancer"},{"key":"11124_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cncr.23553","volume":"113","author":"A Di Giorgio","year":"2008","unstructured":"Di Giorgio A, Naticchioni E, Biacchi D et al (2008) Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315\u2013325. https:\/\/doi.org\/10.1002\/cncr.23553","journal-title":"Cancer"},{"key":"11124_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treat Res"},{"key":"11124_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1245\/s10434-014-4148-x","volume":"22","author":"TR Van Oudheusden","year":"2015","unstructured":"Van Oudheusden TR, Braam HJ, Luyer MDP et al (2015) Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. Ann Surg Oncol 22:1236\u20131242. https:\/\/doi.org\/10.1245\/s10434-014-4148-x","journal-title":"Ann Surg Oncol"},{"key":"11124_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943\u2013953. https:\/\/doi.org\/10.1056\/NEJMoa0908806","journal-title":"N Engl J Med"},{"key":"11124_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","volume":"41","author":"YR Huo","year":"2015","unstructured":"Huo YR, Richards A, Liauw W, Morris DL (2015) Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis. Eur J Surg Oncol 41:1578\u20131589. https:\/\/doi.org\/10.1016\/j.ejso.2015.08.172","journal-title":"Eur J Surg Oncol"},{"key":"11124_CR9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier A-S et al (2014) Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol 40:1467\u20131473. https:\/\/doi.org\/10.1016\/j.ejso.2014.06.006","journal-title":"Eur J Surg Oncol"},{"key":"11124_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","volume":"215","author":"CM Tempany","year":"2000","unstructured":"Tempany CM, Zou KH, Silverman SG et al (2000) Staging of advanced ovarian cancer: comparison of imaging modalities\u2014report from the Radiological Diagnostic Oncology Group. Radiology 215:761\u2013767","journal-title":"Radiology"},{"key":"11124_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.10723","volume":"105","author":"G Passot","year":"2018","unstructured":"Passot G, Dumont F, Go\u00e9r\u00e9 D et al (2018) Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg 105:663\u2013667. https:\/\/doi.org\/10.1002\/bjs.10723","journal-title":"Br J Surg"},{"key":"11124_CR12","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s00330-019-6002-9","volume":"29","author":"AaO Plumb","year":"2019","unstructured":"Plumb AaO, Lambregts D, Bellini D et al (2019) Making useful clinical guidelines: the ESGAR perspective. Eur Radiol 29:3757\u20133760. https:\/\/doi.org\/10.1007\/s00330-019-6002-9","journal-title":"Eur Radiol"},{"key":"11124_CR13","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182:E839\u2013E842. https:\/\/doi.org\/10.1503\/cmaj.090449","journal-title":"CMAJ"},{"key":"11124_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10140-022-02075-9","volume":"29","author":"M El Homsi","year":"2022","unstructured":"El Homsi M, Horvat N, Woodlock DP et al (2022) CT imaging findings in patients with ovarian cancer and acute abdominal symptoms: experience at a tertiary cancer center. Emerg Radiol 29:947\u2013952. https:\/\/doi.org\/10.1007\/s10140-022-02075-9","journal-title":"Emerg Radiol"},{"key":"11124_CR15","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","volume":"30","author":"I van \u2019t Sant","year":"2020","unstructured":"van \u2019t Sant I, Engbersen MP, Bhairosing PA et al (2020) Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol 30:3101\u20133112. https:\/\/doi.org\/10.1007\/s00330-019-06524-x","journal-title":"Eur Radiol"},{"key":"11124_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41571-022-00675-5","volume":"19","author":"V Kepenekian","year":"2022","unstructured":"Kepenekian V, Bhatt A, P\u00e9ron J et al (2022) Advances in the management of peritoneal malignancies. Nat Rev Clin Oncol 19:698\u2013718. https:\/\/doi.org\/10.1038\/s41571-022-00675-5","journal-title":"Nat Rev Clin Oncol"},{"key":"11124_CR17","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1245\/s10434-010-1492-3","volume":"18","author":"TC Chua","year":"2011","unstructured":"Chua TC, Al-Zahrani A, Saxena A et al (2011) Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 18:1582\u20131589. https:\/\/doi.org\/10.1245\/s10434-010-1492-3","journal-title":"Ann Surg Oncol"},{"key":"11124_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"J-L Koh","year":"2009","unstructured":"Koh J-L, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327\u2013333","journal-title":"Ann Surg Oncol"},{"key":"11124_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-31","volume":"12","author":"MJ Rutten","year":"2012","unstructured":"Rutten MJ, Gaarenstroom KN, Van Gorp T et al (2012) Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study. BMC Cancer 12:31. https:\/\/doi.org\/10.1186\/1471-2407-12-31","journal-title":"BMC Cancer"},{"key":"11124_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1471-0528.2008.02033.x","volume":"116","author":"CG Gerestein","year":"2009","unstructured":"Gerestein CG, Eijkemans MJC, de Jong D et al (2009) The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG 116:372\u2013380. https:\/\/doi.org\/10.1111\/j.1471-0528.2008.02033.x","journal-title":"BJOG"},{"key":"11124_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11547-016-0682-x","volume":"122","author":"A Laghi","year":"2017","unstructured":"Laghi A, Bellini D, Rengo M et al (2017) Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med 122:1\u201315","journal-title":"Radiol Med"},{"key":"11124_CR22","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/codi.15368","volume":"22","author":"A Bhatt","year":"2020","unstructured":"Bhatt A, Rousset P, Benzerdjeb N et al (2020) Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index. Colorectal Dis 22:2123\u20132132","journal-title":"Colorectal Dis"},{"key":"11124_CR23","doi-asserted-by":"publisher","first-page":"e24251","DOI":"10.1097\/MD.0000000000024251","volume":"100","author":"L Dong","year":"2021","unstructured":"Dong L, Li K, Peng T (2021) Diagnostic value of diffusion-weighted imaging\/magnetic resonance imaging for peritoneal metastasis from malignant tumor: a systematic review and meta-analysis. Medicine (Baltimore) 100:e24251","journal-title":"Medicine (Baltimore)"},{"key":"11124_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/bjs.10989","volume":"106","author":"I van \u2019t Sant","year":"2019","unstructured":"van \u2019t Sant I, van Eden WJ, Engbersen MP et al (2019) Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery. Br J Surg 106:491\u2013498. https:\/\/doi.org\/10.1002\/bjs.10989","journal-title":"Br J Surg"},{"key":"11124_CR25","doi-asserted-by":"publisher","first-page":"20170519","DOI":"10.1259\/bjr.20170519","volume":"91","author":"S-J Kim","year":"2018","unstructured":"Kim S-J, Lee S-W (2018) Diagnostic accuracy of 18F-FDG PET\/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis. Br J Radiol 91:20170519","journal-title":"Br J Radiol"},{"key":"11124_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s40134-016-0157-9","volume":"4","author":"R Forstner","year":"2016","unstructured":"Forstner R, Meissnitzer M, Cunha TM (2016) Update on imaging of ovarian cancer. Curr Radiol Rep 4:31","journal-title":"Curr Radiol Rep"},{"key":"11124_CR27","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.ejrad.2016.08.006","volume":"85","author":"V Lopez-Lopez","year":"2016","unstructured":"Lopez-Lopez V, Cascales-Campos PA, Gil J et al (2016) Use of 18F-FDG PET\/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and HIPEC. A pending issue. Eur J Radiol 85:1824\u20131828","journal-title":"Eur J Radiol"},{"key":"11124_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/02656736.2017.1366554","volume":"34","author":"W Wang","year":"2018","unstructured":"Wang W, Tan GHC, Chia CS et al (2018) Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)? Int J Hyperthermia 34:524\u2013531","journal-title":"Int J Hyperthermia"},{"key":"11124_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","volume":"19","author":"RC Dresen","year":"2019","unstructured":"Dresen RC, De Vuysere S, De Keyzer F et al (2019) Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging 19:1","journal-title":"Cancer Imaging"},{"key":"11124_CR30","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00330-008-0968-z","volume":"18","author":"TC Kwee","year":"2008","unstructured":"Kwee TC, Takahara T, Ochiai R et al (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937\u20131952. https:\/\/doi.org\/10.1007\/s00330-008-0968-z","journal-title":"Eur Radiol"},{"key":"11124_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejso.2019.02.030","volume":"47","author":"RN Low","year":"2021","unstructured":"Low RN, Barone RM, Rousset P (2021) Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation. Eur J Surg Oncol 47:65\u201374","journal-title":"Eur J Surg Oncol"},{"key":"11124_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","volume":"24","author":"K Michielsen","year":"2014","unstructured":"Michielsen K, Vergote I, Op de Beeck K et al (2014) Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT. Eur Radiol 24:889\u2013901","journal-title":"Eur Radiol"},{"key":"11124_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11124_CR34","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.crad.2017.07.005","volume":"72","author":"A Chandramohan","year":"2017","unstructured":"Chandramohan A, Thrower A, Smith SA et al (2017) \u201cPAUSE\u201d: a method for communicating radiological extent of peritoneal malignancy. Clin Radiol 72:972\u2013980","journal-title":"Clin Radiol"},{"key":"11124_CR35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","volume":"42","author":"L Villeneuve","year":"2016","unstructured":"Villeneuve L, Thivolet A, Bakrin N et al (2016) A new internet tool to report peritoneal malignancy extent. Peritoneal malignancy stage evaluation (PROMISE) application. Eur J Surg Oncol 42:877\u2013882. https:\/\/doi.org\/10.1016\/j.ejso.2016.03.015","journal-title":"Eur J Surg Oncol"},{"key":"11124_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ejca.2013.11.012","volume":"50","author":"JM Borras","year":"2014","unstructured":"European Partnership Action Against Cancer consensus group, Borras JM, Albreht T et al (2014) Policy statement on multidisciplinary cancer care. Eur J Cancer 50:475\u2013480. https:\/\/doi.org\/10.1016\/j.ejca.2013.11.012","journal-title":"Eur J Cancer"},{"key":"11124_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0140-6736(96)02482-8","volume":"348","author":"P Selby","year":"1996","unstructured":"Selby P, Gillis C, Haward R (1996) Benefits from specialised cancer care. Lancet 348:313\u2013318. https:\/\/doi.org\/10.1016\/s0140-6736(96)02482-8","journal-title":"Lancet"},{"key":"11124_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","volume":"119","author":"J Prades","year":"2015","unstructured":"Prades J, Remue E, van Hoof E, Borras JM (2015) Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy 119:464\u2013474. https:\/\/doi.org\/10.1016\/j.healthpol.2014.09.006","journal-title":"Health Policy"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11124-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:05:16Z","timestamp":1745492716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["11124"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11124-5","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is M.J.L.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"V.V. is a member of the Scientific Editorial Board (section: Oncology) for European Radiology. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for these recommendations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required for these recommendations.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}